Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension

被引：14
|
作者：
Rich, S [1 ]
Shillington, A [1 ]
McLaughlin, V [1 ]
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Rush Heart Inst, Ctr Pulm Heart Dis, Chicago, IL 60612 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 11期
关键词：
D O I：
10.1016/j.amjcard.2003.08.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
To test whether the clinical presentation and prognosis of fenfluramine-induced pulmonary hypertension (PH) differs from primary PH (PPH), we compared the clinical. profile and outcome of 10 patients with fenfluramine-induced PH with that of 70 patients with PPH referred to our center over the same time frame and treated identically. Patients with diet pill PH were similar to those with PPH with respect to hemodynamics. However, patients with fenfluramine-induced PH had poorer survival: 1-year survival 50% versus 88%, and 3-year survival 17% versus 60%. (C) 2003 by Excerpta Medica, Inc.
引用
收藏
页码：1366 / 1368
页数：3
相关论文
共 50 条
  • [1] Survival with chronic epoprostenol therapy in patients with porto-pulmonary hypertension: Comparison with primary pulmonary hypertension
    Murali, S
    Bedi, M
    Panyon, J
    Palmer, A
    Svitek, M
    MacGowan, G
    Mathier, M
    McNamara, D
    Fung, J
    [J]. CIRCULATION, 2002, 106 (19) : 679 - 679
  • [2] Primary pulmonary hypertension associated with the use of fenfluramine derivatives
    Simonneau, G
    Fartoukh, M
    Sitbon, O
    Humbert, M
    Jagot, JL
    Hervé, P
    [J]. CHEST, 1998, 114 (03) : 195S - 199S
  • [3] Fenfluramine-induced pulmonary hypertension associated with poor survival
    [J]. Reactions Weekly, 2004, 992 (1) : 3 - 3
  • [4] Comparison of clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus to patients with primary pulmonary hypertension
    Chung, S
    Lee, C
    Lee, E
    Kim, S
    Yoo, B
    Moon, H
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 231 - 231
  • [5] PRIMARY PULMONARY-HYPERTENSION AND FENFLURAMINE USE
    BRENOT, F
    HERVE, P
    PETITPRETZ, P
    PARENT, F
    DUROUX, P
    SIMONNEAU, G
    [J]. BRITISH HEART JOURNAL, 1993, 70 (06): : 537 - 541
  • [6] Clinical Course Of Patients With Pulmonary Hypertension Secondary To Fenfluramine Use
    Willis, A.
    Sundar, K. M.
    Ross, D. S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [7] Lifespan of patients with primary pulmonary hypertension
    Chazova, IE
    Mironova, NA
    [J]. TERAPEVTICHESKII ARKHIV, 2005, 77 (03): : 43 - 48
  • [8] SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION, ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Volkov, A. V.
    Martynyuk, T. V.
    Yudkina, N. N.
    Danilov, N. M.
    Glukhova, S. I. .
    Guseva, N. G.
    Chazova, I. E.
    Nasonova, V. A.
    [J]. TERAPEVTICHESKII ARKHIV, 2012, 84 (05): : 24 - 28
  • [9] ENDOCARDIAL VIABILITY RATIO IS ASSOCIATED WITH SURVIVAL IN PULMONARY HYPERTENSION PATIENTS
    Ondigi, Olivia
    Bilchick, Kenneth C.
    Jalenak, Jay
    Franklin, John
    Boadu, Akua
    Harrison, Kara
    Selinski, Christian
    Ibrahim, Sami
    Ashur, Nicholas
    Baldeo, Cherisse
    Breathett, Khadijah
    Mehta, Nishaki
    Kwon, Younghoon
    Mihalek, Andrew
    Ilonze, Onyedika J.
    Mazimba, Sula
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1893 - 1893
  • [10] ANATOMOPATHOLOGY OF PRIMARY PULMONARY HYPERTENSION - BIOPSY FINDINGS IN PATIENTS AND IN EXPERIMENTAL PULMONARY HYPERTENSION
    BACKMANN, R
    [J]. ZEITSCHRIFT FUR KREISLAUFFORSCHUNG, 1970, 59 (10): : 931 - &
12345